CLINICAL ROLE -
Numerous Clinical Trials Investigate Next Generation of PARP Inhibitors
Therapy effectively treats cells harboring HR deficiencies, including those of specific types of ovarian, breast cancers.
Read More
Clinical Insights Into Advancements in Epithelial Ovarian Cancer Treatment
PARP inhibitors in particular have changed the therapeutic landscape for EOC.
Drug Pathways, Potential Mechanisms of Resistance in PARP Inhibition
Numerous clinical trials are investigating the next generation of PARPi.
Breast Cancer Research, Current Therapeutic Pipeline Provide Significant Advancements in Diagnosis, Treatment
Trends in treatment development involve more targeted, safe, and efficacious therapies.
Expert: Pharmacists Are ‘Very Involved in Holistic Care of Patients With Multiple Myeloma,’ Beyond Treatment Alone
Rachel K. Anderson, PharmD, CSP, clinical program manager at Alliance Rx Walgreens Pharmacy, discusses the impact pharmacists have on the care journey for patients with multiple myeloma.
Current Treatment Modalities, Available Therapeutics for Prostate Cancer See Growth
The disease can often be detected and managed early before a patient experiences signs or symptoms.
Oncology Biosimilars Enter an Era of Expansion
Biosimilars could save consumers more than $100 billion in the coming years.
